Asian Legal Business China Names Chuan Sun a Top 15 TMT Lawyer in China
Asian Legal Business China Names Chuan Sun a Top 15 TMT Lawyer in China
Asian Legal Business China has named Morrison & Foerster partner Chuan Sun to its list of 2020 China Top 15 Technology, Media, and Telecom (TMT) lawyers.
Known for his deep regional and industry expertise, the Shanghai/Hong Kong-based partner has 16 years of experience practicing in both Asia and the United States. He regularly advises multinational corporations, state-owned enterprises, private companies, and PE/VC firms in complex cross-border M&A transactions, joint ventures, strategic alliances, and business separation transactions in the TMT sector. He also has significant experience in technology and strategic corporate-commercial transactions, including outsourcing, manufacturing, distribution, supply and franchising arrangements, and technology licensing arrangements across multiple industries. His TMT regulatory experience includes telecommunications, e-commerce, fintech, internet, cybersecurity, data privacy, cloud computing, as well as telematics.
As noted by Morrison & Foerster’s Beijing/Shanghai managing partner Paul McKenzie, “Chuan’s strengths as a TMT lawyer are clear to see both in the stand-alone tech work he does and in the corporate transactional work we do in the TMT sector. He has a technologist’s grasp of technology and brings a strong practical approach to his work, offering clients effective business solutions to their most complex legal and regulatory issues. These attributes and Morrison & Foerster’s market-leading tech practice have given Chuan the opportunity to work on some of the most cutting edge matters in the sector since he joined the firm in 2016 and we are delighted to see this important recognition of Chuan’s work.”
In 2020, Legal 500 Asia-Pacific noted Chuan as a Leading Lawyer for China TMT: Foreign Firms and recognized him for several additional categories, including China Corporate/M&A: Foreign Firms, China Fintech: Foreign Firms, China Healthcare and Life Sciences: Foreign Firms, China Real Estate and Construction: Foreign Firms, and China Intellectual Property: Foreign Firms.